Morton Grove, IL, United States of America

Leland J Chinn


Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Morton Grove, IL (US) (1976 - 1983)
  • Glenview, IL (US) (1984 - 1987)
  • Montebello, CA (US) (1989 - 1992)

Company Filing History:


Years Active: 1976-1992

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Leland J Chinn: Innovator in Pharmaceutical Advancements

Introduction: Leland J Chinn is a notable inventor based in Morton Grove, Illinois, recognized for his contributions to the field of pharmaceuticals. With a remarkable portfolio of 11 patents, his work has significantly impacted the development of treatments targeting inflammation and allergy.

Latest Patents: Among his latest innovations, Chinn has developed a series of 5-lipoxygenase inhibitors. These inventions encompass compounds and methods aimed at inhibiting lipoxygenase, particularly beneficial in formulating pharmaceutical compositions. One notable formulation includes a pharmaceutical carrier combined with an effective lipoxygenase inhibiting amount of a specific compound formula. The invention targets disorders influenced by the 5-lipoxygenase metabolic pathway, proving its utility in managing local and systemic inflammation, as well as allergy and hypersensitivity reactions.

Career Highlights: Chinn's professional journey includes significant roles at reputable companies such as G.D. Searle & Company. His work in these organizations has been pivotal in translating scientific research into pharmaceutical applications, showcasing the practical implications of his innovations.

Collaborations: Throughout his career, Leland has collaborated with esteemed colleagues including Bipinchandra N Desai and Richard A Mueller. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion: Leland J Chinn stands out as a prolific inventor whose contributions have enhanced therapeutic options for various medical conditions. His dedication to innovation within the pharmaceutical sector continues to pave the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…